Bend, OR 97701, US
Healthcare
www.pleuraflow.com
Clear Catheter Systems, a spinout from a collaboration between MDI Partners (a medical device incubator) and the Cleveland Clinic Foundation, is a Bend, Oregon based privately held medical device company pioneering new technologies to solve the clinical problems associated with obstructed catheters. The companys lead product, the PleuraFlow Active Clearance Technology (ACT) System, was developed by cardiothoracic surgeons to solve the problem of chest tube failure by clot obstruction allowing doctors to manage bleeding and clogging in a safer fashion. By enabling improved postoperative blood evacuation, surgeons are able to utilize minimally invasive drainage tubes, decreasing the surgical footprint and potentially increasing patient comfort. The company has a pipeline of products based on its proprietary tube clearance technologies to resolve catheter clogging in other medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage.
Andrew Firlik focuses on healthcare information technology and connected, data-centric device investments.
Prior to joining FMP, he was a venture partner at Sprout Group and managing director of its healthcare technology spinout, New Leaf Venture Partners, as well as a principal at Canaan Partners. Andrew has led numerous venture capital investments and has helped many early stage companies become successful market leaders. He was a founder (and invented the core technology) of Northstar Neuroscience, which went public in 2006 (NASDAQ: NSTR) and was subsequently acquired by St. Jude Medical.
Prior Year Revenue | Current Year Revenue | Next Year Revenue |
---|---|---|
Sign up as Investor | Sign up as Investor | Sign up as Investor |
Company Age | Employees | Sub-Industry |
---|---|---|
10 years, 5 months | 1 | Other Healthcare |
Company Type | Stock Exchange | Stock Symbol |
---|---|---|
Privately-Held | – | – |